• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

When survival is not enough-Quality of life as a decision endpoint for patients.

作者信息

Walbert Tobias

机构信息

Department of Neurosurgery, Henry Ford Health, Detroit, MI, USA.

出版信息

Neurooncol Pract. 2024 Dec 21;12(2):177-178. doi: 10.1093/nop/npae123. eCollection 2025 Apr.

DOI:10.1093/nop/npae123
PMID:40110069
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11913642/
Abstract
摘要

相似文献

1
When survival is not enough-Quality of life as a decision endpoint for patients.当生存已不足够——生活质量作为患者的决策终点
Neurooncol Pract. 2024 Dec 21;12(2):177-178. doi: 10.1093/nop/npae123. eCollection 2025 Apr.
2
Thrombopoietin receptor agonists for prevention and treatment of chemotherapy-induced thrombocytopenia in patients with solid tumours.血小板生成素受体激动剂用于预防和治疗实体瘤患者化疗引起的血小板减少症。
Cochrane Database Syst Rev. 2017 Nov 27;11(11):CD012035. doi: 10.1002/14651858.CD012035.pub2.
3
Chemotherapy for advanced gastric cancer.晚期胃癌的化疗
Cochrane Database Syst Rev. 2017 Aug 29;8(8):CD004064. doi: 10.1002/14651858.CD004064.pub4.
4
Lumbar sympathectomy versus prostanoids for critical limb ischaemia due to non-reconstructable peripheral arterial disease.腰交感神经切除术与前列腺素类药物治疗因不可重建的外周动脉疾病导致的严重肢体缺血的比较
Cochrane Database Syst Rev. 2018 Apr 16;4(4):CD009366. doi: 10.1002/14651858.CD009366.pub2.
5
Does Augmenting Irradiated Autografts With Free Vascularized Fibula Graft in Patients With Bone Loss From a Malignant Tumor Achieve Union, Function, and Complication Rate Comparably to Patients Without Bone Loss and Augmentation When Reconstructing Intercalary Resections in the Lower Extremity?对于因恶性肿瘤导致骨缺损的患者，在重建下肢节段性切除时，采用带血管游离腓骨移植来增强照射后的自体骨移植，其骨愈合、功能及并发症发生率与无骨缺损且未进行增强的患者相比是否相当？
Clin Orthop Relat Res. 2025 Jun 26. doi: 10.1097/CORR.0000000000003599.
6
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
7
Automated monitoring compared to standard care for the early detection of sepsis in critically ill patients.与标准护理相比，自动监测用于危重症患者脓毒症的早期检测
Cochrane Database Syst Rev. 2018 Jun 25;6(6):CD012404. doi: 10.1002/14651858.CD012404.pub2.
8
Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens for treatment failure in adults and adolescents living with HIV in low-resource settings.在资源匮乏地区，针对感染艾滋病毒的成人和青少年治疗失败时何时更换一线抗逆转录病毒治疗方案的最佳监测策略。
Cochrane Database Syst Rev. 2010 Apr 14(4):CD008494. doi: 10.1002/14651858.CD008494.
9
Occlusal interventions for managing temporomandibular disorders.咬合干预治疗颞下颌关节紊乱病。
Cochrane Database Syst Rev. 2024 Sep 16;9(9):CD012850. doi: 10.1002/14651858.CD012850.pub2.
10
Laser therapy for treating hypertrophic and keloid scars.激光疗法治疗增生性瘢痕和瘢痕疙瘩。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD011642. doi: 10.1002/14651858.CD011642.pub2.

本文引用的文献

1
Preoperative patient-reported physical health-related quality of life predicts short-term postoperative outcomes in brain tumor patients.术前患者报告的与身体健康相关的生活质量可预测脑肿瘤患者的短期术后结局。
J Neurooncol. 2024 May;167(3):477-485. doi: 10.1007/s11060-024-04627-0. Epub 2024 Mar 4.
2
Baseline functioning scales of EORTC QLQ-C30 predict overall survival in patients with gastrointestinal cancer: a meta-analysis.EORTC QLQ-C30 基线功能量表预测胃肠道癌症患者的总生存：一项荟萃分析。
Qual Life Res. 2024 Jun;33(6):1455-1468. doi: 10.1007/s11136-023-03591-y. Epub 2024 Jan 16.
3
Neurocognitive, symptom, and health-related quality of life outcomes of a randomized trial of bevacizumab for newly diagnosed glioblastoma (NRG/RTOG 0825).一项贝伐珠单抗治疗新诊断胶质母细胞瘤的随机试验（NRG/RTOG 0825）的神经认知、症状和健康相关生活质量结局。
Neuro Oncol. 2021 Jul 1;23(7):1125-1138. doi: 10.1093/neuonc/noab011.
4
Glioma patient-reported outcome assessment in clinical care and research: a Response Assessment in Neuro-Oncology collaborative report.胶质母细胞瘤患者报告结局评估在临床护理和研究中的应用：神经肿瘤学协作组的报告。
Lancet Oncol. 2020 Feb;21(2):e97-e103. doi: 10.1016/S1470-2045(19)30796-X.
5
Psychometric evaluation of an item bank for computerized adaptive testing of the EORTC QLQ-C30 cognitive functioning dimension in cancer patients.癌症患者欧洲癌症研究与治疗组织核心生活质量问卷（EORTC QLQ-C30）认知功能维度计算机自适应测试题库的心理测量学评估
Qual Life Res. 2017 Nov;26(11):2919-2929. doi: 10.1007/s11136-017-1648-8. Epub 2017 Jul 13.
6
Health-Related Quality of Life in a Randomized Phase III Study of Bevacizumab, Temozolomide, and Radiotherapy in Newly Diagnosed Glioblastoma.在新诊断的胶质母细胞瘤中贝伐单抗、替莫唑胺和放疗的随机 III 期研究中的健康相关生活质量。
J Clin Oncol. 2015 Jul 1;33(19):2166-75. doi: 10.1200/JCO.2014.60.3217. Epub 2015 May 26.
7
Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma.贝伐珠单抗联合放疗-替莫唑胺治疗新诊断的胶质母细胞瘤。
N Engl J Med. 2014 Feb 20;370(8):709-22. doi: 10.1056/NEJMoa1308345.
8
A randomized trial of bevacizumab for newly diagnosed glioblastoma.贝伐珠单抗治疗新诊断的胶质母细胞瘤的随机试验。
N Engl J Med. 2014 Feb 20;370(8):699-708. doi: 10.1056/NEJMoa1308573.
9
The cancer patient and quality of life.癌症患者与生活质量。
Oncologist. 2002;7(2):120-5. doi: 10.1634/theoncologist.7-2-120.